Somewhat Positive News Coverage Likely to Impact Stryker Corporation (SYK) Share Price

Headlines about Stryker Corporation (NYSE:SYK) have been trending somewhat positive on Friday, Alpha One Sentiment Analysis reports. The research firm, a division of Accern, identifies positive and negative news coverage by reviewing more than twenty million news and blog sources. Alpha One ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Stryker Corporation earned a media sentiment score of 0.13 on Alpha One’s scale. Alpha One also gave media headlines about the medical technology company an impact score of 74 out of 100, indicating that recent news coverage is likely to have an effect on the stock’s share price in the immediate future.

Here are some of the media headlines that may have effected AlphaOne’s rankings:

Insider Buying and Selling by Quarter for Stryker Corporation (NYSE:SYK)

SYK has been the topic of several research reports. Morgan Stanley upped their target price on Stryker Corporation from $135.00 to $145.00 and gave the company an “overweight” rating in a research report on Monday, March 13th. Cowen and Company set a $150.00 target price on Stryker Corporation and gave the company an “outperform” rating in a research report on Wednesday, April 26th. Canaccord Genuity reissued a “buy” rating and issued a $137.00 target price on shares of Stryker Corporation in a research report on Monday, February 27th. Royal Bank of Canada reissued an “outperform” rating and issued a $140.00 target price (up from $135.00) on shares of Stryker Corporation in a research report on Wednesday, April 26th. Finally, Goldman Sachs Group, Inc. (The) initiated coverage on Stryker Corporation in a research report on Tuesday, May 16th. They issued a “neutral” rating and a $129.00 target price on the stock. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and twelve have given a buy rating to the company. Stryker Corporation has a consensus rating of “Hold” and a consensus target price of $134.29.

Shares of Stryker Corporation (NYSE:SYK) traded up 0.72% on Friday, reaching $142.24. 1,582,595 shares of the company were exchanged. The company has a market capitalization of $53.16 billion, a P/E ratio of 31.96 and a beta of 0.81. The stock has a 50 day moving average of $138.76 and a 200-day moving average of $128.53. Stryker Corporation has a 52-week low of $106.48 and a 52-week high of $145.62.

Stryker Corporation (NYSE:SYK) last announced its quarterly earnings results on Tuesday, April 25th. The medical technology company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.43 by $0.05. Stryker Corporation had a net margin of 14.33% and a return on equity of 24.26%. The company had revenue of $2.96 billion for the quarter, compared to the consensus estimate of $2.90 billion. During the same quarter in the prior year, the firm earned $1.24 earnings per share. The company’s revenue for the quarter was up 18.4% compared to the same quarter last year. On average, analysts predict that Stryker Corporation will post $6.43 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, July 31st. Shareholders of record on Friday, June 30th will be issued a $0.425 dividend. This represents a $1.70 annualized dividend and a dividend yield of 1.20%. The ex-dividend date of this dividend is Wednesday, June 28th. Stryker Corporation’s dividend payout ratio (DPR) is presently 38.20%.

In related news, insider David Floyd sold 7,381 shares of the company’s stock in a transaction that occurred on Monday, June 5th. The shares were sold at an average price of $144.70, for a total transaction of $1,068,030.70. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Timothy J. Scannell sold 13,322 shares of the company’s stock in a transaction that occurred on Tuesday, May 2nd. The shares were sold at an average price of $135.89, for a total transaction of $1,810,326.58. The disclosure for this sale can be found here. 7.40% of the stock is owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: “Somewhat Positive News Coverage Likely to Impact Stryker Corporation (SYK) Share Price” was originally reported by sleekmoney and is the sole property of of sleekmoney. If you are accessing this story on another publication, it was copied illegally and republished in violation of United States and international copyright & trademark laws. The original version of this story can be accessed at https://sleekmoney.com/somewhat-positive-news-coverage-likely-to-impact-stryker-corporation-syk-share-price/1916040.html.

About Stryker Corporation

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/somewhat-positive-news-coverage-likely-to-impact-stryker-corporation-syk-share-price/1916040.html

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *